Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a PRAME pMHC targeted T cell engager for solid tumor therapy. | MAbs | 2025 | 40994043 | PubTator, text mining | PubMed |
| A highly selective TCR-mimic antibody reveals unexpected mechanisms of HBV peptide-MHC recognition and previously unknown target biology. | MAbs | 2025 | 40990156 | PubTator, text mining | PubMed |
| Mechanisms, Clinical Trials, and New Treatments for BCG-Unresponsive in Nonmuscle Invasive Bladder Cancer. | Cancer Med | 2025 | 40948378 | PubTator, text mining | PubMed |
| MAGE-A3 as a target for cancer immunotherapy: A systematic review of clinical and preclinical evidence. | Curr Probl Cancer | 2025 | 40743771 | PubTator, text mining | PubMed |
Targeting of acute myeloid leukemia by five-gene engineered T cells expressing transgenic T-cell receptor specific to WT1, chimeric antigenic receptor specific to GM-CSF receptor, bispecific T-cell engager specific to CD33, and tEGFR suicide gene system. | Immunother Adv | 2025 | 40735486 | PubTator, text mining | PubMed |
| Microfluidic Devices for Manufacture of Therapeutic Extracellular Vesicles: Advances and Opportunities. | J Extracell Vesicles | 2025 | 40704561 | PubTator, text mining | PubMed |
| Retrospective prognostic evaluation and single-cell transcriptomic analyses of non-small cell lung carcinoma with malignant pleural effusion. | Transl Cancer Res | 2025 | 40687263 | PubTator, text mining | PubMed |
| Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validation. | Mol Ther Nucleic Acids | 2025 | 40673161 | PubTator, text mining | PubMed |
| The role of exosomes in immunopathology and potential therapeutic implications. | Cell Mol Immunol | 2025 | 40659888 | PubTator, text mining | PubMed |
| Predicting Immunotherapy Efficacy with Machine Learning in Gastrointestinal Cancers: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2025 | 40649716 | PubTator, text mining | PubMed |
| Causal Effects of the Plasma Proteome on Vascular Dementia Risk: A Mendelian Randomization Study with Experimental Validation. | Cell Mol Neurobiol | 2025 | 40622612 | PubTator, text mining | PubMed |
| Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges. | World J Transplant | 2025 | 40535484 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Precision Delivery Systems for Biopharmaceuticals: Innovations, Challenges, and Therapeutic Potential. | Pharmaceutics | 2025 | 40430932 | PubTator, text mining | PubMed |
| Twin Study Provides Heritability Estimates for 2321 Plasma Proteins and Assesses Missing SNP Heritability. | J Proteome Res | 2025 | 40425507 | PubTator, text mining | PubMed |
| Targeting Tumor Differentiation Grade-related Genes Prognostic Signature Including COL5A1 Based on Single-cell RNA-seq in Gastric Cancer. | Int J Med Sci | 2025 | 40386054 | PubTator, text mining | PubMed |
| Unveiling MAGEA3: a novel predictive biomarker for bevacizumab resistance in colorectal cancer. | Cancer Drug Resist | 2025 | 40342736 | PubTator, text mining | PubMed |
| Identification of immunogenic HLA-A*02:01 epitopes associated with HCC for immunotherapy development. | Hepatol Commun | 2025 | 40008881 | PubTator, text mining | PubMed |
| Construction of a radiogenomic signature based on endoplasmic reticulum stress for predicting prognosis and systemic combination therapy response in hepatocellular carcinoma. | BMC Cancer | 2025 | 39849389 | PubTator, text mining | PubMed |
| Melanoma antigen genes (MAGE); novel functional targets in multiple myeloma. | Semin Hematol | 2025 | 39580273 | PubTator, text mining | PubMed |
| Bladder cancer biomarkers: current approaches and future directions. | Front Oncol | 2024 | 39678505 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=3